View Older Stories

Sep 18, 2026 06:44AM Eli Lilly (LLY) PT Raised to $1,284 at Guggenheim

Sep 15, 2026 01:22AM Berenberg Upgrades Eli Lilly (LLY) to Buy

Sep 15, 2026 01:21AM Berenberg Upgrades Eli Lilly (LLY) to Buy

Sep 9, 2026 08:11AM BMO Capital on Eli Lilly's (LLY) Positioning for 2H26

Sep 3, 2026 05:25AM Bessent at Charlotte Private Luncheon warns China AI win would 'negate all else', targets 80% compute share by 2028

Sep 2, 2026 09:29AM JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)

Sep 1, 2026 09:14AM BMO Capital: 'Eli Lilly (LLY) to Acquire Precision I&I Biotech Merida Bio'

Aug 31, 2026 07:01AM Lilly reports one-year data on Taltz and Zepbound combined in psoriatic disease

Aug 27, 2026 08:27AM Novo Nordisk seeks China approval for oral Wegovy drug

Aug 26, 2026 06:45AM Lilly study links Zepbound to lower costs in adults over 55

Aug 25, 2026 01:54PM PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg

Aug 19, 2026 03:33PM Amplitude Therapeutics signs taRNA vaccine deal with Eli Lilly

Aug 12, 2026 12:04PM Morgan Stanley analysts visit National Resilience facility in Ohio, clients include LLY and AZN

Aug 12, 2026 05:57AM Lilly files six lawsuits over illegal sales of unapproved retatrutide

Aug 11, 2026 07:03AM Eli Lilly selects Veeva Vault CRM for global deployment

Aug 11, 2026 06:44AM BofA raises obesity market forecast on Lilly stock international strength

Aug 6, 2026 06:09AM Eli Lilly (LLY) PT Raised to $1,330 at Wells Fargo

Aug 6, 2026 05:07AM Eli Lilly (LLY) PT Raised to $1,400 at BMO Capital

Aug 5, 2026 07:19AM Eli Lilly shares pop as weight-loss drug demand fuels guidance hike

Aug 5, 2026 06:48AM Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c ; Offers Guidance

Aug 5, 2026 04:04AM Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock

Aug 4, 2026 11:22AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1.4 puts into quarter results

Aug 4, 2026 04:41AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1 put into quarter results

Aug 3, 2026 11:00AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1.5 puts with into quarter results

Aug 3, 2026 07:45AM FDA grants Lilly's olomorasib breakthrough therapy status for pancreatic cancer

Aug 1, 2026 10:00AM U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage

Jul 30, 2026 08:59AM Eli Lilly and Resilience to invest $750 million in US manufacturing

Jul 23, 2026 10:54AM Lilly to file for next-gen obesity drug approval in early 2027

Jul 21, 2026 07:36AM Novo Nordisk sues Eli Lilly over weight-loss drug ads

Jul 21, 2026 06:45AM H.C. Wainwright Downgrades AtaiBeckley Inc (ATAI) to Neutral

Jul 17, 2026 09:13AM UBS Reiterates Buy Rating on Eli Lilly (LLY) on Deal to Acquire ATAI

Jul 16, 2026 10:00AM Oppenheimer on AtaiBeckley Inc (ATAI): 'LLY Acquisition Validates Psychedelic Advantages'

Jul 15, 2026 07:09PM Lilly Said To Near Deal For Psychedelic Drugmaker Ataibeckley - Bloomberg

Jul 14, 2026 02:27PM Lilly’s Retevmo approved by FDA for RET Tumors

Jul 14, 2026 06:25AM Eli Lilly (LLY) PT Raised to $1,385 at Bernstein SocGen Group

Jul 13, 2026 03:27PM Teva lawsuit against Eli Lilly over Forteo revived by appeals court

Jul 13, 2026 06:53AM Eli Lilly (LLY) PT Raised to $1,273 at Guggenheim

Jul 9, 2026 07:31AM Lilly to present 16 Alzheimer's abstracts at AAIC 2026 in London

Jul 8, 2026 04:37PM Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis

Jul 8, 2026 08:53AM Eli Lilly (LLY) PT Raised to $1,370 at Truist Securities

Jul 6, 2026 06:45AM Eli Lilly (LLY) PT Raised to $1,350 at Cantor Fitzgerald as Strong Q2 Results Likely

Jul 6, 2026 06:43AM Abbvie (ABBV) PT Raised to $265 at Cantor Fitzgerald: Broadly Strong Q2 Results Expected

Jul 1, 2026 07:59AM RBC Capital Reiterates Outperform Rating on Eli Lilly (LLY)

Jun 30, 2026 03:26AM Innovent and Lilly strike China deal for breast cancer drug

Jun 29, 2026 04:29PM FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing

Jun 29, 2026 04:20PM FDA selects 7 companies for domestic drug manufacturing pilot

Jun 29, 2026 06:14AM Sandoz submits generic obesity drug applications to FDA

Jun 23, 2026 12:20PM Eli Lilly plans European weight-loss pill launch by early 2027

Jun 23, 2026 08:05AM Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas

Jun 22, 2026 11:00AM Eli Lilly & Co. (LLY) Declares $1.73 Quarterly Dividend; 0.6% Yield

View Older Stories